USFDA inspects Cadila Healthcare's Pharmaceutical Technology Centre at Ahmedabad
Cadila Healthcare announced that the USFDA inspected the Pharmaceutical Technology Centre (PTC), the company's state-ofthe-art R&D facility located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from 18 March to 22 March 2019.
At the end of the inspection, no observations (483) have been issued.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 22 2019 | 4:15 PM IST